Table 1.
Characteristics of participants.
Patient experts (N = 7) | Other experts (N = 16) | |
---|---|---|
Country | ||
European Union | – | 3 |
Canada | – | 3 |
United Kingdom | 7 | 4 |
United States | – | 6 |
Role | ||
Regulator | – | 5 |
Academic researcher | – | 7 |
Payer | – | 1 |
Industry expert | – | 3 |
Patient | 5 | – |
Patient advocate | 2 | – |
Gender | ||
Male | 5 | 6 |
Female | 2 | 10 |